Laurel Wealth Advisors, Inc. Viatris Inc Transaction History

Laurel Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $373,244 - $460,272	-37,512 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $14,724 - $23,115	1,501 Added 4.17%	37,512 $408,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $435,372 - $528,641	36,011 New	36,011 $487,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $163,351 - $222,850	-12,020 Closed	0 $0
Q4 2020 Mar 03, 2021	BUY	$14.3 - $18.74 $171,886 - $225,254	12,020 New	12,020 $225,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.